Carolyn Keever-Taylor, Ph.D.
Director, Blood and Marrow Transplantation Processing Laboratories
Dr. Carolyn Keever-Taylor has is a recognized expert in the field of Cellular Therapy with over 100 full length publications, including journal articles and book chapters. She is an active in a number of professional societies including the International Society for Cellular Therapy (ISCT) where she has served on the executive board of directors and several committees and the American Society for Blood and Marrow Transplantation(ASBMT) where she serves on the advisory board. Dr. Keever-Taylor has also participated actively in the Foundation for the Accreditation of Cellular Therapy (FACT) since its founding in 1998 to set standards and to perform and train BMT program inspections. She currently represents FACT in the Worldwide Blood and Marrow Transplant (WBMT) organization executive board and on key subcommittees as well as serving on the steering committees of several multi-center clinical trials involving novel methods of cellular therapy product processing or use of such products for new indications.
Dr. Keever-Taylor's primary research interests have been focused on immune reconstitution after BMT and the use of immunotherapy to improve transplant outcomes. She has been a principle or co-investigator on several protocols conducted under investigational new drug (IND) approvals. The most recent project uses cytotoxic T cell lines from transplant donors prepared in the laboratory to recognize common viral pathogens (EBV, CMV, Adenovirus) that cause considerable morbidity and mortality in BMT patients who have not yet recovered a fully functioning immune system.